Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.
about
Inducing and Administering Tregs to Treat Human DiseaseRegulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in TransplantationIn vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animalsThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseasePosttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.Effects of rapamycin combined with low dose prednisone in patients with chronic immune thrombocytopenia.Targeting Janus tyrosine kinase 3 (JAK3) with an inhibitor induces secretion of TGF-β by CD4+ T cells.IL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154-CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized MiceCurrent and future approaches for control of graft-versus-host disease.Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune HomeostasisImmunoregulatory functions of mTOR inhibition.Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesisCan antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantationThe biology of graft-versus-host disease: experimental systems instructing clinical practice.Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapyA phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease.Pathogenesis and management of graft-versus-host disease.The role of the thymus in tolerance.Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.Contradictory immune response in post liver transplantation hepatitis B and C.Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host diseaseImmune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.Renal transplantation in patients with sarcoidosis: a French multicenter studySuperiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer.Mechanisms of cyclic nucleotide phosphodiesterases in modulating T cell responses in murine graft-versus-host disease.A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model.Generation of human regulatory T cells de novo with suppressive function prevent xenogeneic graft versus host disease.HDAC inhibition and graft versus host diseaseSelective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantationIn vivo cell tracking with bioluminescence imaging.Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantationPhase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancer.Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease.Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells.Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation.HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host Disease
P2860
Q26772723-DBACEE3A-DC01-4453-B8DB-DE01870380E9Q26784460-A499B6A8-84E6-4C02-8E2B-68E3F79A74FAQ27006069-63E6F9D5-F92A-4392-BD67-C17CF5C59240Q28076264-93D4979E-6376-4F08-A1AA-8B2A749F3AE3Q33381227-72F170CF-8641-49FD-A781-105D5D666D5FQ33412264-84847847-ACD6-49C0-AECF-F73B786DEDDAQ33577441-D100376F-F3BF-44DC-BE1E-9517C86F5CDDQ33586165-44A07EB3-2560-4E11-B164-621D26500C20Q33642625-95F4BCC9-E664-4B2C-AE62-AB4171596F80Q33729446-C9CD4BE3-4C67-4DD5-B491-373A734EDC92Q33761278-76B2E663-D5D6-4D9C-81B3-356287966D37Q33779715-FC957025-D8BD-40A9-A483-7AB94791B3BCQ33800533-3C78C1DC-D5DC-47E7-82AA-7E7AB59E2B91Q33898020-55F8E46D-1409-4BE2-8569-8D0E931139ADQ33917175-76A24A14-3F8D-4BC2-AF5F-D5C39AB51CCBQ33917765-A720B705-580D-4121-9847-4E04264DC77EQ33964687-768F5D62-9B69-4038-BCCE-3B2E30CDB62AQ34044170-B266AB26-3971-4A65-8BF5-4B658FCD6F6DQ34077479-AB39B24F-A143-484D-B03E-24A27D30684DQ34103905-7146F423-1519-4568-BC9C-EDB8BB3CC72AQ34144161-1F7DC3A2-AB20-4AEB-9309-5A2D3599AC82Q34152074-BFCD3B09-2150-4A94-9714-9F2073E010DAQ34279929-FD9A47B3-2524-4A01-B614-8AB3C4AD835EQ34371122-36264998-C47D-44CF-B217-EF4AD308D859Q34400439-C5B4BEE2-1FD0-4E73-9302-CDE1BF9E3A8CQ34405427-5D5FF54F-744A-4AA8-BD8D-ED1756C291C4Q34536661-E8D53670-D356-472F-9A55-52B696B581FEQ34618635-2AB1D2AE-19E6-4B72-AD92-116C04ED611DQ34732865-0046A053-DE06-40D1-9EF4-D0CCB62FF82CQ34996186-17EB0402-1ED7-4494-A0B0-9D85BFAB84F3Q35016985-A4DD30B4-F1BE-4B70-8985-027746FEA601Q35037993-A2D057DE-90FC-4F54-BD8F-C64866E0551FQ35128301-A79847A2-CB89-4D5A-A71B-F4C572517E83Q35162679-7A2FF4B2-F21C-4271-8275-717BC1DA16EAQ35184589-CC8F741F-305F-4C60-9F93-6285EDFFD231Q35510507-2BF1733E-7C28-4E85-89DF-825E5A6EF88EQ35642843-87393222-19B9-4225-B0F3-DC8BC267805BQ35743830-99105B27-6F8C-43A2-92CB-B31C2BD44697Q35750957-75ED2D56-893B-447C-A3A5-C7D489F2AB40Q35815893-7BEA3593-44F2-4981-839C-3C6F21B40766
P2860
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Inhibition of CD4+CD25+ regula ...... dent interleukin-2 production.
@en
type
label
Inhibition of CD4+CD25+ regula ...... dent interleukin-2 production.
@en
prefLabel
Inhibition of CD4+CD25+ regula ...... dent interleukin-2 production.
@en
P2093
P2860
P1433
P1476
Inhibition of CD4+CD25+ regula ...... dent interleukin-2 production.
@en
P2093
Andreas Beilhack
Jeanette Baker
Martin Buess
Robert S Negrin
Robert Zeiser
Stephan Schulz
Vu H Nguyen
P2860
P304
P356
10.1182/BLOOD-2006-01-0329
P407
P577
2006-03-07T00:00:00Z